These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray. Chou D; Peng HY; Lin TB; Lai CY; Hsieh MC; Wen YC; Lee AS; Wang HH; Yang PS; Chen GD; Ho YC Neuropharmacology; 2018 Sep; 139():1-12. PubMed ID: 29953886 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression. Zhao X; Venkata SL; Moaddel R; Luckenbaugh DA; Brutsche NE; Ibrahim L; Zarate CA; Mager DE; Wainer IW Br J Clin Pharmacol; 2012 Aug; 74(2):304-14. PubMed ID: 22295895 [TBL] [Abstract][Full Text] [Related]
10. Ketamine metabolite (2R,6R)-hydroxynorketamine enhances aggression via periaqueductal gray glutamatergic transmission. Ye L; Ko CY; Huang Y; Zheng C; Zheng Y; Chou D Neuropharmacology; 2019 Oct; 157():107667. PubMed ID: 31207251 [TBL] [Abstract][Full Text] [Related]
11. Chiral LC-MS/MS method for the simultaneous determination of (R,S)-ketamine, (R,S)-norketamine, and (2R,6R;2S,6S)-hydroxynorketamine in mouse plasma and brain. Toki H; Yamaguchi JI; Mizuno-Yasuhira A; Endo H J Pharm Biomed Anal; 2023 Feb; 224():115168. PubMed ID: 36473323 [TBL] [Abstract][Full Text] [Related]
12. (R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic doses. Zanos P; Highland JN; Liu X; Troppoli TA; Georgiou P; Lovett J; Morris PJ; Stewart BW; Thomas CJ; Thompson SM; Moaddel R; Gould TD Br J Pharmacol; 2019 Jul; 176(14):2573-2592. PubMed ID: 30941749 [TBL] [Abstract][Full Text] [Related]
13. Loss of the sustained antidepressant-like effect of (2R,6R)-hydroxynorketamine in NMDA receptor GluN2D subunit knockout mice. Yamagishi A; Ikekubo Y; Mishina M; Ikeda K; Ide S J Pharmacol Sci; 2024 Mar; 154(3):203-208. PubMed ID: 38395521 [TBL] [Abstract][Full Text] [Related]
14. Subchronic administration of (R,S)-ketamine induces ketamine ring hydroxylation in Wistar rats. Moaddel R; Sanghvi M; Ramamoorthy A; Jozwiak K; Singh N; Green C; O'Loughlin K; Torjman M; Wainer IW J Pharm Biomed Anal; 2016 Aug; 127():3-8. PubMed ID: 27017097 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic (R,S)-ketamine and (2S,6S)-hydroxynorketamine Decrease Fear Expression by Differentially Modulating Fear Neural Ensembles. Mastrodonato A; Jin M; Kee N; Lanio M; Tapia J; Quintana L; Muñoz Zamora A; Deng SX; Xu X; Landry DW; Denny CA Biol Psychiatry; 2024 Oct; ():. PubMed ID: 39389408 [TBL] [Abstract][Full Text] [Related]
16. Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit. Yao N; Skiteva O; Zhang X; Svenningsson P; Chergui K Mol Psychiatry; 2018 Oct; 23(10):2066-2077. PubMed ID: 29158578 [TBL] [Abstract][Full Text] [Related]
17. A Pharmacological Evaluation of the Analgesic Effect and Hippocampal Protein Modulation of the Ketamine Metabolite (2R,6R)-Hydroxynorketamine in Murine Pain Models. Das V; Basovich MB; Thomas CJ; Kroin JS; Buvanendran A; McCarthy RJ Anesth Analg; 2024 May; 138(5):1094-1106. PubMed ID: 37319016 [TBL] [Abstract][Full Text] [Related]